TY - JOUR
T1 - The genetics of congenital heart disease.. understanding and improving long-Term outcomes in congenital heart disease
T2 - A review for the general cardiologist and primary care physician
AU - Abigail Simmons, M.
AU - Brueckner, Martina
N1 - Publisher Copyright:
© 2017 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Purpose of review This review has two purposes: To provide an updated review of the genetic causes of congenital heart disease (CHD) and the clinical implications of these genetic mutations, and to provide a clinical algorithm for clinicians considering a genetics evaluation of a CHD patient. Recent findings A large portion of congenital heart disease is thought to have a significant genetic contribution, and at this time a genetic cause can be identified in approximately 35% of patients. Through the advances made possible by next generation sequencing, many of the comorbidities that are frequently seen in patients with genetic congenital heart disease patients can be attributed to the genetic mutation that caused the congenital heart disease. These comorbidities are both cardiac and noncardiac and include: neurodevelopmental disability, pulmonary disease, heart failure, renal dysfunction, arrhythmia and an increased risk of malignancy. Identification of the genetic cause of congenital heart disease helps reduce patient morbidity and mortality by improving preventive and early intervention therapies to address these comorbidities. Summary Through an understanding of the clinical implications of the genetic underpinning of congenital heart disease, clinicians can provide care tailored to an individual patient and continue to improve the outcomes of congenital heart disease patients.
AB - Purpose of review This review has two purposes: To provide an updated review of the genetic causes of congenital heart disease (CHD) and the clinical implications of these genetic mutations, and to provide a clinical algorithm for clinicians considering a genetics evaluation of a CHD patient. Recent findings A large portion of congenital heart disease is thought to have a significant genetic contribution, and at this time a genetic cause can be identified in approximately 35% of patients. Through the advances made possible by next generation sequencing, many of the comorbidities that are frequently seen in patients with genetic congenital heart disease patients can be attributed to the genetic mutation that caused the congenital heart disease. These comorbidities are both cardiac and noncardiac and include: neurodevelopmental disability, pulmonary disease, heart failure, renal dysfunction, arrhythmia and an increased risk of malignancy. Identification of the genetic cause of congenital heart disease helps reduce patient morbidity and mortality by improving preventive and early intervention therapies to address these comorbidities. Summary Through an understanding of the clinical implications of the genetic underpinning of congenital heart disease, clinicians can provide care tailored to an individual patient and continue to improve the outcomes of congenital heart disease patients.
KW - clinical outcomes
KW - congenital heart disease
KW - genetics
UR - http://www.scopus.com/inward/record.url?scp=85029116515&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029116515&partnerID=8YFLogxK
U2 - 10.1097/MOP.0000000000000538
DO - 10.1097/MOP.0000000000000538
M3 - Review article
C2 - 28872494
AN - SCOPUS:85029116515
SN - 1040-8703
VL - 29
SP - 520
EP - 528
JO - Current Opinion in Pediatrics
JF - Current Opinion in Pediatrics
IS - 5
ER -